health - "medicine"

Recent findings that a mutant gene can cause abnormal overactivity in the immune system could be significant in the search for treatments of Huntington's disease (HD) and other degenerative diseases such as Alzheimer's and Parkinson's, according to new research led by scientists at UCL (University College London) and published today in the Journal of Experimental medicine.

Upside to 'epidemic' surgery: 83 percent successful in return to play, new research finds.Eighty-three percent of athletes who had 'Tommy John' elbow reconstruction surgery were able to return to the same or better level of play, according to a study released today at the 2008 American Orthopaedic Society for Sports medicine Annual Meeting at JW Marriott Orlando Grande Lakes. While reassuring to athletes, the study authors find the trend of more and more young athletes requiring the surgery, alarming.read more

HOUSTON (AP) -- When Dr. Michael E. DeBakey pushed forward with his groundbreaking research and maverick approach to medicine a half century ago, heart surgery was a medical marvel....

A natural compound from magnolia cones blocks a pathway for cancer growth that was previously considered 'undruggable,' researchers have found. A laboratory led by Jack Arbiser, MD, PhD, at Emory University School of medicine, has been studying the compound honokiol, found in Japanese and Chinese herbal medicines, since discovering its ability to inhibit tumor growth in mice in 2003.read more

Calistoga Pharmaceuticals, Inc., a company dedicated to developing innovative medicines for the treatment of cancer and inflammatory diseases, announced the initiation of a Phase 1 clinical trial of its lead compound, CAL-101, a small molecule phosphoinositide-3 kinase (PI3K) delta inhibitor, in patients with hematologic cancer. 'We at Calistoga are very pleased to be entering our first oncology trial.

TheraGenetics Limited, a personalized medicine diagnostics company that is developing and commercializing a portfolio of pharmacogenetic diagnostic tests to guide and improve the treatment of central nervous system (CNS) disorders, announced that it has completed an agreement with the Centre for

With the current boom for minimally invasive anti-aging treatments, the first person many people go to is their physician. Moreover, between new State regulations and the need for industry-leading clinical education, practitioners agree that more timely and accessible information is required.

Makers of the SinuCleanse® line of nasal washing products, today announced a product for children, the Kids Mist T. With the recent ban by the Food and Drug Administration on many over-the-counter cough and cold medicines for children, parents have been left with few options for easing kids' sinus symptoms.

(Society of Nuclear Medicine) SNM -- an international scientific and professional organization of more than 16,000 members dedicated to promoting the practical applications, technology and science of molecular imaging and nuclear medicine -- has awarded $300,000 in research grants to support molecular imaging research. The grants, supported by SNM's Education and Research Foundation, represent the society's commitment to advancing molecular imaging and therapy by supporting the next generation of researchers.

(Indiana University) A National Palliative Care Research Center award to Greg A. Sachs, M.D. of the Indiana University School of medicine and the Regenstrief Institute will support the evaluation of the feasibility of incorporating an outpatient palliative care program for patients with dementia into the primary care setting.